tiprankstipranks
Vivoryon Therapeutics AG (DE:05Y)
:05Y
Germany Market

Vivoryon Therapeutics AG (05Y) Financial Statements

Compare
28 Followers

Vivoryon Therapeutics AG Financial Overview

Vivoryon Therapeutics AG's market cap is currently €48.95M. The company's EPS TTM is €-1.196; its P/E ratio is ―; Vivoryon Therapeutics AG is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ -3.62M€ 0.00€ 10.76M€ 0.00€ 0.00
Gross Profit€ -3.10M€ -161.00K€ 9.03M€ -146.00K€ -88.00K
Operating Income€ -28.84M€ -29.13M€ -12.81M€ -16.02M€ -7.77M
EBITDA€ -28.35M€ -28.17M€ -12.03M€ -16.34M€ -7.63M
Net Income€ -28.34M€ -28.16M€ -12.65M€ -16.51M€ -7.82M
Balance Sheet
Cash & Short-Term Investments€ 28.58M€ 26.55M€ 14.66M€ 26.31M€ 41.52M
Total Assets€ 30.83M€ 31.38M€ 24.52M€ 29.75M€ 45.86M
Total Debt€ 38.00K€ 132.00K€ 224.00K€ 314.00K€ 406.00K
Net Debt€ -18.52M€ -26.42M€ -14.44M€ -25.99M€ -41.12M
Total Liabilities€ 4.55M€ 4.87M€ 7.96M€ 3.53M€ 3.20M
Stockholders' Equity€ 26.28M€ 26.51M€ 16.56M€ 26.22M€ 42.66M
Cash Flow
Free Cash Flow€ -22.05M€ -21.81M€ -11.29M€ -14.65M€ -11.65M
Operating Cash Flow€ -21.54M€ -21.79M€ -11.26M€ -14.01M€ -11.61M
Investing Cash Flow€ -10.51M€ -13.00K€ -28.00K€ -640.00K€ -47.00K
Financing Cash Flow€ 24.16M€ 33.38M€ -827.00K€ -90.00K€ 49.35M
Currency in EUR

Vivoryon Therapeutics AG Earnings and Revenue History

Vivoryon Therapeutics AG Debt to Assets

Vivoryon Therapeutics AG Cash Flow

Vivoryon Therapeutics AG Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis